Search
for
Sort by
Research 451–480 of 1000+
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- Hair Regrowth in Alopecia Areata Patients: Insights from a Case Study Using Mesenchymal Stem Cell Conditioned Media
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- Comparison of efficacy of intra-lesional injections of platelet rich plasma therapy versus intralesional triamcinolone acetonide in the treatment of patients with alopecia areata at a tertiary care hospital
- Serum Interleukin 19 in Patients with Alopecia Areata
- Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecial Totalis and Alopecia Universalis: A Randomized, Double-Blind, Placebo-Controlled Trial
- Apremilast for extensive and treatment-resistant alopecia areata: a retrospective analysis of five patients
- Refractory alopecia areata with single hairs imitating frontal fibrosing alopecia: a prospective observational study
- A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle
- COMPARATIVE STUDY OF TWO CONCENTRATIONS (2.5MG/ML AND 5 MG/ML) OF INTRALESIONAL TRIAMCINOLONE ACETONIDE IN THE TREATMENT OF ALOPECIA AREATA
- Real‐life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Interleukin 15 Gene Polymorphism in patients with Alopecia Areata
- SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Hearing impairment in patients with alopecia areata
- Salt-losing tubulopathy and chronic dermatitis
- Quality of life in patients with alopecia areata: a hospital‐based cross‐sectional study
- Evaluation of quality of life scores and family impact scales in pediatric patients with alopecia areata: a cross‐sectional cohort study
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Modifiable Lifestyle and Behavioral Factors Associated With Disease Severity in Androgenetic Alopecia: A Propensity Score–Matched Cross‐Sectional Study
- Assessment of Alopecia Areata Disease Severity in Pediatric Patients
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- BH15 The burden of alopecia areata: examining baseline health-related quality of life and clinical assessment tools
- Supplementary Material for: Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Hair density response to photobiomodulation in canine alopecia X is measured reliably with an ordinal scale: a randomized, controlled, double-blind study
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Does zinc have a role in alopecia areata? A clinic-biochemical study